Allianz Asset Management Gmb H Concert Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$16.83 - $21.66 $1.93 Million - $2.48 Million	-114,659 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$19.24 - $28.03 $32,650 - $47,566	-1,697 Reduced 1.46%	114,659 $2.63 Million
Q4 2017 Feb 13, 2018	SELL	$13.96 - $29.05 $37,831 - $78,725	-2,710 Reduced 2.28%	116,356 $3.01 Million
Q3 2017 Nov 13, 2017	SELL	$13.91 - $15.31 $9,514 - $10,472	-684 Reduced 0.57%	119,066 $1.76 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-1,422 Reduced 1.17%	119,750 $1.67 Million
Q1 2017 Apr 17, 2019	SELL	N/A	-4,956 Reduced 3.93%	121,172 $2.07 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-21,719 Reduced 14.69%	126,128 $1.3 Million
Q3 2016 Apr 17, 2019	BUY	N/A	147,847	147,847 $1.5 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.